Role of ischemic preconditioning and the portosystemic shunt in the prevention of liver and lung damage after rat liver transplantation

Transplantation

Volumn 76, Issue 2, 2003, Pages 282-289

  Fernandez L ^a   Heredia, N ^b   Peralta, C ^a   Xaus, C ^a   Roselló Catafau, Joan ^a   Rimola, A ^b   Marco, A ^b   Serafin A ^a   Deulofeu, R ^b   Gelpi E ^a   Grande, L ^b  

^a INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^b Inst Invest Biomed August Pi S ^*

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; ALANINE AMINOTRANSFERASE; HYALURONIC ACID; MALONALDEHYDE; MYELOPEROXIDASE; NUCLEOTIDE; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COLD INJURY; CONTROLLED STUDY; DISEASE ASSOCIATION; ENDOTHELIUM LESION; ENZYME ACTIVITY; HEART INFARCTION PREVENTION; HISTOLOGY; INFLAMMATION; LIVER CELL DAMAGE; LIVER INJURY; LIVER TRANSPLANTATION; LUNG INJURY; MALE; MEASUREMENT; NONHUMAN; PORTOSYSTEMIC ANASTOMOSIS; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RAT;

ANIMALS; COLD; ENERGY METABOLISM; HEPATOCYTES; ISCHEMIC PRECONDITIONING; LIVER DISEASES; LIVER TRANSPLANTATION; LUNG DISEASES; MALE; PORTASYSTEMIC SHUNT, SURGICAL; POSTOPERATIVE COMPLICATIONS; RATS; RATS, SPRAGUE-DAWLEY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0043269262     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000067529.82245.4E     Document Type: Article

References (47)

1. Clavien PA, Harvey PRC, Strasberg SM. Preservation and reperfusion injuries in liver allografts. An overview of and synthesis of current studies. Transplantation 1992; 53: 957.
2. Matuschak GM, Rinaldo JE, Pinski MR, et al. Effect of end stage liver failure on the incidence and resolution of the adult respiratory distress syndrome. J Crit Care 1987; 2: 162.
3. Sankary HN, Yin DP, Chong ASF, et al. The portosystemic shunt protects liver against ischemic reperfusion injury. Transplantation 1999; 68: 958.
4. Carvalho EM, Massarollo PCB, Isern MR, et al. Pulmonary evolution in conventional liver transplantation with venovenous bypass and the piggyback method. Transplant Proc 1999; 31: 3064.
5. Sankary HN, Foster O, Brown E, et al. Do splanchnic viscera contribute to liver preservation-reperfusion injury? Transplantation 1996; 61: 1142.
6. Okuaki Y, Miyazaki H, Zeniya M, et al. Splenectomy-reduced hepatic injury induced by ischemia/reperfusion in the rat. Liver 1996; 16: 188.
7. Urata K, Brault A, Rocheleau B, et al. Role of Kupffer cells in the survival after rat liver transplantation with long portal vein clamping times. Transpl Int 2000; 13: 420.
8. Shibuya H, Ohkohchi N, Seya K, et al. Kupffer cells generate superoxide anions and modulate reperfusion injury in rat liver after cold preservation. Hepatology 1997; 25: 356.
9. Strieter RM, Kunkel SL, Bone RC. Role of tumor necrosis factor-α in disease states and inflammation. Crit Care Med 1993; 21: S447.
10. Colletti LM, Burtch GD, Remick DG, et al. The production of tumor necrosis factor alpha and the development of a pulmonary capillary injury following hepatic ischemia/reperfusion. Transplantation 1990; 49: 268.
11. Suzuki S, Nakamura S, Sakaguchi T, et al. Pathophysiological appraisal of a rat model of total ischemia with an extracorporeal portosystemic shunt. J Surg Res 1998; 80: 22.
12. Omokawa S, Arai Y, Saito H, et al. A simple model of total hepatectomy, hepatic ischemia and extrahepatic portal obstruction in rats using spleen transposition. Jpn J Surg 1991; 21: 50.
13. Gonce ME, Brackett DJ, Squires RA, et al. A new model for inducing total hepatic ischemia while preventing circulatory collapse secondary to splanchnic vascular congestion. Shock 1995; 3: 440.
14. Suzuki M, Fukuhara K, Unno M, et al. Correlation between plasma and hepatic phosphatidylcholine hydroperoxide, energy charge and total glutathione content in ischemia reperfusion injury of rat liver. Hepatogastroenterology 2000; 47: 1082.
15. Isozaki H, Adam R, Gigou M, et al. Experimental study of the protective effect of intermittent hepatic pedicle clamping in the rat. Br J Surg 1992; 79: 310.
16. Delriviere L, Kamada N, Kobayashi E, et al. Portosystemic shunt for orthotopic liver transplantation in the rat. J Surg Res 1994; 56: 457.
17. Goto S, Kamada N, Moore T, et al. The influence of intestinal congestion on survival of preserved liver grafts in rat liver transplantation. Transplantation 1994; 58: 974.
18. Marzi I, Knee J, Menger MD, et al. Hepatic microcirculatory disturbances due to portal vein clamping in the orthotopic rat liver transplantation model. Transplantation 1991; 52: 432.
19. Peralta C, Bartrons R, Riera L, et al. Hepatic preconditioning preserves energy metabolism during sustained ischemia. Am J Physiol Gastrointest Liver Physiol 2000; 279: G163.
20. Peralta C, Hotter G, Closa D, et al. Protective effect of preconditioning on the injury associated to hepatic ischemia-reperfusion in the rat: role of nitric oxide and adenosine. Hepatology 1997; 25: 934.
21. Peralta C, Hotter G, Closa D, et al. The protective role of adenosine in inducing nitric oxide synthesis in rat liver ischemic preconditioning is mediated by activation of adenosine A2 receptors. Hepatology 1999; 29: 126.
22. Zapletal C, Maksan SM, Lehmann T, et al. Ischemic preconditioning improves liver microcirculation after ischemia-reperfusion. Transpl Proc 1999; 31: 3260.
23. Peralta C, Prats N, Xaus C, et al. Protective effect of liver ischemic preconditioning on liver and lung injury induced by hepatic ischemia-reperfusion in the rat. Hepatology 1999; 30: 1481.
24. Peralta C, Fernández L, Panés J, et al. Preconditioning protects against systemic disorders associated with hepatic ischemia-reperfusion through blockade of tumor necrosis factor-induced P-selectin up-regulation in the rat. Hepatology 2001; 33: 100.
25. Yin DP, Sankary HN, Chong AS, et al. Protective effects of ischemic preconditioning on liver preservation-reperfusion injury in rats. Transplantation 1998; 66: 152.
26. Arai M, Thurman RG, Lemasters JJ. Ischemic preconditioning of rat livers against cold storage-reperfusion injury: role of nonparenchymal cells and the phenomenon of heterologous preconditioning. Liver Transpl 2001; 7: 292.
27. Kamada N, Calne RY. Orthotopic liver transplantation in the rat. Technique using cuff portal vein anastomosis and biliary drainage. Transplantation 1979; 28: 47.
28. Takei Y, Gao W, Hijioka T, et al. Increase in survival of liver grafts after rinsing with warm ringer's solution due to improvement of hepatic microcirculation. Transplantation 1991; 52: 225.
29. Takei Y, Marzi I, Kauffman FC, et al. Increase in survival time of liver transplants by protease inhibitors and a calcium channel blocker, nisoldipine. Transplantation 1990; 50: 14.
30. Steffen R, Krom RAF, Fegurson D, et al. Comparison of University of Wisconsin (UW) and Eurocollins (EC) preservation solutions in a rat liver transplant model. Transpl Int 1990; 3: 133.
31. Bengmark S, Börgesson B, Olin T. Development of portosystemic shunts after subcutaneous transposition of the spleen in the rat. Am J Surg 1973; 125: 757-762.
32. Reinders ME, van Wagensveld BA, van Gulik TM, et al. Hyaluronic acid uptake in the assessment of sinusoidal endothelial cell damage after cold storage and normothermic reperfusion of rat livers. Transpl Int 1996; 9: 446-453.
33. Itasaka H, Suehiro T, Wakiyama S, et al. Significance of hyaluronic acid for evaluation of hepatic endothelial cell damage after cold preservation/reperfusion. J Surg Res 1995; 59: 589-595.
34. Settaf A, Zahidy M, Elimadi A, et al. S-15176 reduces the hepatic injury in rats subjected to experimental ischemia and reperfusion. Eur J Pharmacol 2000; 406: 281-292.
35. Wodopia R, Ko HS, Billian J, et al. Hypoxia decreases proteins involved in epithelial electrolyte transport in A549 cells and rat lung. Am J Physiol Lung Cell Mol Physiol 2000; 279: L1110.
36. Serracino-Inglott F, Habib NA, Mathie RT. Hepatic ischemia-reperfusion injury. Am J Surg 2001; 181: 160-166.
37. Shimizu H, Miyazaki M, Ito H. Mechanism of cold ischemia-reperfusion-induced graft injury in orthotopic liver transplantation in rats. Hepatogastroenterology 2001; 48: 216-219.
38. Man K, Lo CM, Ng IO, et al. Liver transplantation in rats using a small-for-size grafts: a study of hemodynamic and morphological changes. Arch Surg 2001; 136: 280-285.
39. Klar E, Angelescu M, Zapletal C, et al. Definition of maximum cold ischemia time without reduction of graft quality in clinical liver transplantation. Transplant Proc 1998; 30: 3683-3685.
40. Suzuki S, Nakamura S, Serizawa A, et al. Role of Kupffer cells and the spleen in modulation of endotoxin-induced liver injury after partial hepatectomy. Hepatology 1996; 24: 219-225.
41. Arai M, Mochida S, Ohno A, et al. Selective bowel decontamination of recipients for prevention against liver injury following orthotopic liver transplantation: evaluation with rat models. Hepatology 1998; 27: 123-127.
42. Goto M, Takei Y, Kawano S. Tumor necrosis factor and endotoxin in the pathogenesis of liver and pulmonary injuries after orthotopic transplantation in the rat. Hepatology 1992; 16: 487-493.
43. Paulsen AW, Whitten CW, Ramsay MA, et al. Considerations for anesthetic management during veno-venous bypass in adult hepatic transplantation. Anesth Analg 1989; 68: 489-496.
44. Khoury G, Mann M, Porot M, et al. Air embolism associated with venovenous bypass during orthotopic liver transplantation. Anesthiol 1987; 67: 848-851.
45. Rossi G, Langer M, Maggi U, et al. Veno-venous bypass versus no bypass in orthotopic liver transplantation: hemodynamic, metabolic, and renal data. Transplant Proc 1998; 30: 1871-1873.
46. Tzakis AG, Reyes J, Nour B, et al. Temporary end to side portocaval shunt in orthotopic hepatic transplantation in humans. Surg Gynecol Obstet 1993; 176: 180-182.
47. Figueras J, Lladó L, Ramos, et al. Temporary portocaval shunt during liver transplantation with vena cava preservation. Results of a prospective randomized study. Liver Transpl. 2001; 7: 904-911.